Objectives. Bisphosphonates related osteonecrosis of the jaw (BRONJ) is a pathological
condition characterized by bone exposure or latent infection in patients treated with the drug …

The aim of this longitudinal study is to present data from 76 female patients treated with
bisphosphonates (BPs) for postmenopausal osteoporosis and referred to the Unit of Oral …

Patients taking bisphosphonates and other anti-resorptive drugs are likely to attend general
dental practice. The term 'bisphosphonate'is often immediately associated with …

The aim of the present study is to assess the clinical and histological healing of a post-
extractive alveolus following the procedure for socket preservation, in a patient receiving …

Introduction: The purpose of this article is to determine the prevalence of ONJ in patients
who have undergone intravenous bisphosphonate therapy, and relate the risk factors …

Introduction. Medication–related osteonecrosis of the jaws (MRONJ) is a severe side effect
of antiresorptive or antiangiogenic therapy that manifests as an exposed bone …

The incidence rate of ONJ in patients with osteoporosis who are being treated with oral
bisphosphonates has been estimated to be between 1 case per 10,000 patienttreatment …

Bisfosfonat bileşikleri malignansiye bağlı olarak gelişen hiperkalseminin düzenlenmesinde
ve ayrıca, meme, prostat ve akciğer kanserlerine bağlı tümörlerin ve multipl myelomaya …

Resumen MONIVAS PALOMERO, C. et al. Estudio experimental para la valoración de la
cicatrización ósea con Ácido Zoledrónico en ratas Wistar. Sanid. Mil.[online]. 2015, vol. 71 …

Absztrakt: Bevezetés: A gyógyszer okozta állcsontnekrózis (MRONJ) prognózisában
szerepet játszó lehetséges rizikófaktorok–az egyes faktorok esetében kapott eltérő …